Inventor · disambiguated record
Hans-Guido Wendel
Also filed as: WENDEL HANS · WENDEL HANS G · WENDEL HANS GUIDO
5 granted patents·12 pending applications·29 citations·filing 2004–2025
74Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER7SLOAN KETTERING INST CANCER3WENDEL HANS-GUIDO2COLD SPRING HARBOR LAB1FRIDMAN JORDAN S1
Top patents by PatentIndex Score
17 records- 0188US9241941B2Methods for treatment of lymphomas with mutations in cell cycle genesSLOAN KETTERING INST CANCER·Filed 2013·Granted Jan 26, 2016·16 cites·10 claims
- 0285US8883510B2Thrombocyte function determination method using a resonatorGEHRING FRANK K·Filed 2010·Granted Nov 11, 2014·12 cites·15 claims
- 0367US11261232B2TNFRSF14 / HVEM proteins and methods of use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Mar 1, 2022·1 cites·13 claims
- 0457US2022185866A1Tnfrsf14 / hvem proteins and methods of use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 0554US2017334966A1Anti-tumor antibody-tumor suppressor fusion protein compositions and methods of use for the treatment of cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Application pending·0 cites
- 0652US2025361218A1Agents and methods for treating dysproliferative diseasesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2025·Application pending·0 cites
- 0748US2016331750A1Methods for treatment of lymphomas with mutations in cell cycle genesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Application pending·0 cites
- 0847US12215090B2Agents and methods for treating dysproliferative diseasesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Feb 4, 2025·0 cites·31 claims
- 0945US2015299278A1Cancer-specific suicide gene for cell-based and gene therapySLOAN KETTERING INST CANCER·Filed 2013·Application pending·0 cites
- 1042US2018305426A1Cancer-specific suicide gene for cell-based and gene therapySLOAN KETTERING INST CANCER RES·Filed 2018·Application pending·0 cites
- 1142US2021181179A1Diagnosis and treatment of immunotherapy-induced neurotoxicityMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 1241US2009186839A1Model for studying the role of genes in chemoresistanceCOLD SPRING HARBOR LAB·Filed 2007·Application pending·0 cites
- 1340US2014079698A1Anti-tumor antibody-tumor suppressor fusion protein compositions and methods of use for the treatment of cancerWENDEL HANS-GUIDO·Filed 2012·Application pending·0 cites
- 1439US2006294604A1Model for studying the role of genes in tumor resistance to chemotherapyFRIDMAN JORDAN S·Filed 2004·Application pending·0 cites
- 1532US2015219624A1Methods for identifying anti-cancer compoundsSLOAN KETTERING INST CANCER·Filed 2015·Application pending·0 cites
- 1631US2018223368A1Methods for diagnosing and treating follicular lymphomaMemorial Sloan Ketteting Cancer Center·Filed 2016·Application pending·0 cites
- 1727US9624491B2Methods and compositions for the detection and treatment of cancer involving miRNAs and miRNA inhibitors and targetsWENDEL HANS-GUIDO·Filed 2011·Granted Apr 18, 2017·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Hans-Guido Wendel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →